News

COVID-19 Update

Mast is pleased to announce the launch of NEW additions to the MASTDISCS^® AST range for EUCAST and CLSI methodology:

Mast Group Ltd. are pleased to announce the expansion of their molecular product portfolio with the launch of the New MAST ISOPLEX^® CRE-ART  kit for the rapid molecular detection of carbapenemase producing organisms (CPOs).

Mast are pleased to announce the launch of the NEW  MASTDISCS^® Combi  ESBL Detection Set (EUCAST) with the new disc potencies as recommended by EUCAST for the reliable detection of ESBL producing Enterobacterales.

MAST^® ASSURE Bacterial Agglutinating Antisera products are a comprehensive range of polyvalent and monovalent diagnostic antisera for bacterial identification.

Mast Group Ltd. exhibited at the Institute of Biomedical Science Congress 2019 at the International Convention Centre in Birmingham 22^nd – 25^th September 2019, and it proved to be a triumph!

Public Health England have recently reported a 20% increase in Syphilis diagnoses